u2-os cells

TGR5 is a potent TGR5(GPCR19) agonist.

PI-1840(IC50 = 27 nM)is a reversible and selective chymotrypsin-like (CT-L) inhibitor, with little proteasome proteolytic effects on trypsin-like (T-L) and postglutamyl-peptide-hydrolysis-like (PGPH-L).

Tapcin is a dual inhibitor of topoisomerase I and II, with IC50 values of 203 nM and 71 nM, respectively. It effectively inhibits the proliferation of cancer cells such as A-375, HeLa, Huh7.5, U2-OS, A549, Caco-2, and HT29, with IC50 values of 441, 1.04, 40.5, 0.002, 0.006, 0.287, and 0.842 nM, respectively. Additionally, Tapcin demonstrates antitumor activity in HT29 xenograft models.